|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/505 | |
| C07D 403/04 | |||
| A61K 31/506 | |||
| A61P 35/00 |
| (11) | Number of the document | 2925744 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13859400.7 |
| Date of filing the European patent application | 2013-11-26 | |
| (97) | Date of publication of the European application | 2015-10-07 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/SE2013/051387 |
| Date | 2013-11-26 |
| (87) | Number | WO 2014/084778 |
| Date | 2014-06-05 |
| (30) | Number | Date | Country code |
| 1251332 | 2012-11-27 | SE | |
| 201261797022 P | 2012-11-27 | US |
| (72) |
SCOBIE, Martin, SE
HELLEDAY, Thomas, SE
KOOLMEISTER, Tobias, SE
JACQUES, Sylvain, FR
DESROSES, Matthieu, SE
JACQUES-CORDONNIER, Marie-Caroline, FR
|
| (73) |
Thomas Helledays Stiftelse För Medicinsk Forskning,
c/o Oxcia AB Norrbackagatan 70 C, 113 34 Stockholm,
SE
|
| (54) | PYRIMIDINE-2,4-DIAMINE DERIVATIVES FOR TREATMENT OF CANCER |
| PYRIMIDINE-2,4-DIAMINE DERIVATIVES FOR TREATMENT OF CANCER |